LON:FUM Futura Medical (FUM) Share Price, News & Analysis → Move Your Money Before May 1 (From Stansberry Research) (Ad) Free FUM Stock Alerts GBX 35.45 +0.05 (+0.14%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range 35.20▼ 35.8950-Day Range 35.40▼ 45.5552-Week Range 23.28▼ 67Volume244,893 shsAverage Volume898,833 shsMarket Capitalization£106.86 millionP/E RatioN/ADividend Yield4.55%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines Get Futura Medical alerts: Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About Futura Medical Stock (LON:FUM)Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.Read More FUM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FUM Stock News HeadlinesApril 11, 2024 | finance.yahoo.comFutura Medical targets global expansion with Eroxon, eyeing profitability in 2024March 14, 2024 | finance.yahoo.comFutura Medical plc (FUM.L)April 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. March 13, 2024 | finance.yahoo.comThose who invested in Futura Medical (LON:FUM) five years ago are up 175%February 6, 2024 | msn.comFutura Medical shares swell as sales of erectile dysfunction gel boomJanuary 31, 2024 | lse.co.ukFutura Medical Share ChatJanuary 29, 2024 | finance.yahoo.comWith 59% institutional ownership, Futura Medical plc (LON:FUM) is a favorite amongst the big gunsNovember 8, 2023 | msn.comM8 to market Futura’s erectile dysfunction gel in more countriesApril 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. November 7, 2023 | finance.yahoo.comFutura Medical continues global expansion with Latin America announcementNovember 3, 2023 | finance.yahoo.comHere's Why We're Not At All Concerned With Futura Medical's (LON:FUM) Cash Burn SituationOctober 19, 2023 | proactiveinvestors.comFutura Medical hails first UAE stockist of ED treatmentOctober 19, 2023 | proactiveinvestors.comFutura Medical ED drug roll continues apaceOctober 5, 2023 | finance.yahoo.comFutura Medical's (LON:FUM) investors will be pleased with their strong 256% return over the last five yearsOctober 2, 2023 | marketwatch.comFutura Medical Gets European Patent for Erectile Dysfunction TreatmentOctober 2, 2023 | proactiveinvestors.comFutura Medical secures European patent protection for ED gel out to 2040September 18, 2023 | proactiveinvestors.com.auFutura Medical targets profitability as erectile dysfunction gel gains commercial tractionSeptember 18, 2023 | proactiveinvestors.comFutura Medical: Pieces of the jigsaw falling into place, says...August 22, 2023 | finance.yahoo.comWith 58% institutional ownership, Futura Medical plc (LON:FUM) is a favorite amongst the big gunsJuly 18, 2023 | proactiveinvestors.comFutura Medical "absolutely delighted" with US commercialisation agreementJune 22, 2023 | proactiveinvestors.comFutura Medical says early sales of erectile dysfunction gel...Futura Medical says early sales of erectile dysfunction gel met...June 13, 2023 | markets.businessinsider.comFutura Granted FDA Approval For OTC Marketing Of MED3000 Gel For Erectile DysfunctionJune 13, 2023 | uk.finance.yahoo.comFAMDF - Futura Medical plcJune 12, 2023 | finance.yahoo.comUS FDA Grants for Over-the-Counter Marketing Authorization to Futura for Fast-Acting Topical Gel, MED3000, to Treat Erectile DysfunctionJune 12, 2023 | proactiveinvestors.comFutura Medical shares jump 22% in the wake of FDA green lightJune 12, 2023 | proactiveinvestors.comFutura Medical in discussions with US partners after gaining FDA approvalApril 25, 2023 | fool.comFutura Medical Plc (LSE: FUM)See More Headlines Receive FUM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Futura Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings9/16/2020Today4/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:FUM CUSIPN/A CIKN/A Webwww.futuramedical.com Phone+44-1483-685670FaxN/AEmployees12Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-5,110,000.00 Net Margins-299.73% Pretax MarginN/A Return on Equity-66.35% Return on Assets-39.40% Debt Debt-to-Equity RatioN/A Current Ratio4.15 Quick Ratio5.73 Sales & Book Value Annual Sales£1.70 million Price / Sales62.86 Cash FlowGBX 1.73 per share Price / Cash Flow20.43 Book ValueGBX 3 per share Price / Book11.82Miscellaneous Outstanding Shares301,450,000Free FloatN/AMarket Cap£106.86 million OptionableNot Optionable Beta1.26 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. James Henry Barder (Age 65)CEO & Executive Director Comp: $397.08kMs. Angela Hildreth (Age 44)COO, Finance Director, Company Secretary & Executive Director Comp: $310.8kMr. Kenneth William James (Age 72)Head of R&D & Executive Director Comp: $284.59kDr. William Duncan Potter (Age 76)Chief Scientific Officer & Adviser to the Board Graham SmithHead of Alliance Partnerships & SupplyKevin LangridgeHead of QualityMore ExecutivesKey CompetitorsVerseonLON:VSNTiziana Life SciencesLON:TILSMereo BioPharma Group plc (MPH.L)LON:MPHScancellLON:SCLPFaron Pharmaceuticals OyLON:FARNView All Competitors FUM Stock Analysis - Frequently Asked Questions How have FUM shares performed in 2024? Futura Medical's stock was trading at GBX 25.50 at the start of the year. Since then, FUM stock has increased by 39.0% and is now trading at GBX 35.45. View the best growth stocks for 2024 here. How were Futura Medical's earnings last quarter? Futura Medical plc (LON:FUM) posted its earnings results on Wednesday, September, 16th. The company reported ($0.44) earnings per share (EPS) for the quarter. Futura Medical had a negative net margin of 299.73% and a negative trailing twelve-month return on equity of 66.35%. What other stocks do shareholders of Futura Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Futura Medical investors own include Indivior (INDV), Tullow Oil (TLW), Bigblu Broadband (BBB), Directa Plus (DCTA), Genel Energy (GENL), Lakehouse (LAKE), Petrel Resources (PET), People's Operator (TPOP), CityFibre Infrastructure (CITY) and Paysafe Group (PAYS). How do I buy shares of Futura Medical? Shares of FUM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:FUM) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Futura Medical plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.